tiprankstipranks
Trending News
More News >
Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS

Apellis Pharmaceuticals (APLS) Revenue

Compare
985 Followers

Apellis Pharmaceuticals Revenue

Apellis Pharmaceuticals had a revenue of 458.58M in the quarter ending Sep 30, 2025, with 156.92%. This bring the company's revenue in the last twelve months to 1.02B, Decreased 34.68%. In the fiscal year ending Dec 31, 2024, Apellis Pharmaceuticals had annual revenue of 781.37M with 97.02% growth.
Revenue (ttm)
1.02B
Revenue Growth
42.11%
P/S Ratio
4.09
Revenue/Employee
$1,108,322
Employees
705
Market Cap
$3.19B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
781.37M384.78M+197.02%
Dec 31, 2023
396.59M321.17M+525.83%
Dec 31, 2022
75.42M8.86M+113.31%
Dec 31, 2021
66.56M-184.08M+26.56%
Dec 31, 2020
250.65M-25,064,600,000.00%
Dec 31, 2019
Dec 31, 2018
Dec 31, 2017
Dec 31, 2016